Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Kintor Pharmaceutical Announces Preliminary Results from the Proxalutamide's Clinical Trial 2020-12-11 19:44
Innovent Announces First Patient Dosed in Phase 2 Pivotal Trial of IBI310 (CTLA-4) combined with TYVYT® (sintilimab injection) for the treatment of second-line or above Advanced Cervical Cancer 2020-12-11 09:02
Antengene Announces Acceptance of IND Application in China for a Phase 3 Clinical Trial of ATG-010 (Selinexor) in Combination with Bortezomib and Dexamethasone (SVd) for the Treatment of rrMM 2020-12-11 08:00
European Union Intellectual Property Office Revokes Counterfeiter's Fake AQUAGOLD® Design Registration and Orders Payment to Aquavit of All Legal Fees and Costs 2020-12-11 03:10
INOVIO and Advaccine Announce First Dosing of Subject in Phase 2 Clinical Trial for COVID-19 DNA Vaccine Candidate INO-4800 in China 2020-12-10 21:00
Bill and Melinda Gates call for collaboration, continued innovation to overcome challenges of delivering COVID-19 scientific breakthroughs to the world 2020-12-10 13:01
Stellar Results from Kintor's GT90001 and Opdivo Combo Therapy in the Second-line Treatment of Advanced Liver Cancer: ORR Reached up to 40% 2020-12-10 12:14
Ascentage Pharma Announces Updates on the Clinical Development of APG-2575, including an ORR of 70% in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia 2020-12-10 09:03
CStone's Partner Blueprint Medicines Announces U.S. FDA Approval of GAVRETO (pralsetinib) for the Treatment of Patients with Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid Cancer 2020-12-10 08:30
PharmAbcine presents the latest data of the ongoing Phase Ib mTNBC trial at SABCS 2020 2020-12-09 23:00
INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Anal Dysplasia Caused by HPV-16/18 2020-12-09 21:00
Zelgen Selects Industry's First Automated, End-to-End Drug Safety System 2020-12-09 05:07
Novaliq Announces First Patient Randomized in the Phase 3 trial ESSENCE-2 of CyclASol® Topical Ophthalmic Solution for the Treatment of Dry Eye Disease 2020-12-08 21:00
Henlius Adalimumab Biosimilar Approved by NMPA 2020-12-08 21:00
Nuance Pharma Closes Series D Financing 2020-12-08 17:34
Nuance Pharma Closes Series D Financing 2020-12-08 16:00
Ascentage Pharma Announces Positive Data from Pivotal Phase II Studies of HQP1351 (Olverembatinib) in Patients with TKI-Resistant Chronic Myeloid Leukemia (CML) at 2020 American Society of Hematology (ASH) Annual Meeting 2020-12-08 08:16
A­­­­­izon Lauded by Frost & Sullivan for Its AI-powered Platform that Enables Pharma Companies to Achieve Smart and Continuous Manufacturing 2020-12-08 01:57
PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery 2020-12-07 22:37
Through Strategic Collaboration with GenScript ProBio, Initium Therapeutics Plans to Utilize GenScript ProBio's Berkeley Lights Beacon Platform to Expand Their Antibody Drug Pipeline 2020-12-07 22:00
1 267 268 269 270 271 412